BRIEF-Merck presents updated findings from Keytruda
December 05, 2016 at 10:54 AM EST
* Updated Keytruda (Pembrolizumab) findings in patients with relapsed or refractory primary mediastinal large B-cell lymphoma presented at 58th annual meeting of the American society of Hematology
